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ABSTRACT
Papillomatosis papulosa confluens reticulata et pigmentata is a rare dermatosis that presents clinically with 
pigmented, papillomatous, hyperkeratotic plaques with central confluence and reticulated peripheral pat-
tern. The etiology remains unclear but current data points to a keratinization defect as the main patholog-
ical mechanism. There is one case report in the literature of a UV-induced Papillomatosis papulosa conflu-
ens reticulata et pigmentata. We present a 16-year old patient with clinical and histological diagnosis of con-
fluent and reticulated papillomatosis. The characteristic lesions involved sun-exposed areas and developed 
after intense sun exposure. As an etiologic factor, ultraviolet light may lead to mechanical epidermal dam-
age and further keratinization modification. On the other hand, in the setting of genetically predetermined 
resistance to UV-immunosuppression mechanisms, the newly formed epidermal antigens could potentially 
trigger an immune reaction resulting in skin eruption.
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Papillomatosis papulosa confluens reticula-
ta et pigmentata (PPCRP) (Morbus Gougerot-Car-
teaud, Syndroma Gougerot-Carteaud) was first de-
scribed in the literature in 1927. It is a rare derma-
tosis with unknown etiology and very characteristic 
clinical presentation. The disease occurs predomi-
nantly in young adults (17-21 years old on the aver-
age), with no racial or sexual predilection. Clinical-
ly, it presents with hyperpigmented, papillomatous, 
confluent, scaly patches and plaques, involving the 
neck, axillae and upper trunk in a rhomboid pattern. 
Gougerot and Carteaud proposed a set of diagnostic 
criteria which are still in use today, though new crite-
ria have been proposed recently. The classical criteria 
include the presence of scaly, brown macules, patch-
es and papules that appear reticulated or papilloma-
tous; negative fungal staining; and classical histolo-
gy with papillomatous and hyperkeratotic epidermis 
and scarce perivascular lymphocytic infiltrate (9). In 
2006 Davis et al, proposed new criteria derived from 
a large retrospective study of patients with PPCRP. 
These are 1. Typical clinical presentation; 2. Involve-
ment of the upper trunk and neck; 3. Fungal stain-
ing of scales negative for fungus; 4. No response to 
antifungal treatment; 5. Excellent response to mino-
cycline (5).
PPCRP is an asymptomatic skin disease without 
systemic involvement. Nevertheless, the rash is cos-
metically unacceptable which warrants active treat-
ment. Several treatment modalities have been tried 
and greatest success was reported with oral minocy-
cline (7,22,25), oral and topical retinoids (13,17,26,27) 
and topical calcipotriol (1, 2). Isolated case reports of 
good treatment outcomes include other antibiotics 
(6), antifungals (3) and local mupirocin (8).
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CLINICAL CASE
A 15-year old girl was admitted to our clinic 
with a rash on the abdomen and back. The rash oc-
curred two weeks after excessive sun exposure at the 
seaside. The initial changes were pigmented macules 
that later on transformed into greyish, flat, confluent 
papules. The skin looked ‘dirty’. There was no family 
or personal history of similar disorders, nor personal 
history of concurrent diseases, endocrine disorders 
or intake of any medicinal products.
Physical examination revealed small grayish-
brown, flat, confluent hyperkeratotic papules. 
The lesions were distributed over photoexposed 
areas of the body, mainly the abdomen and back, 
sparing the skin that was under the swimming suit. 
(Fig. 1, Fig. 2). Laboratory investigations did not 
show any pathology. Fungal staining was negative. 
On histological examination the epidermis was 
papillomatous, hyperkeratotic and atrophic with 
vacuolar degeneration and increased melanin in the 
basal layer. Scarce perivascular lymphocytic infiltrate 
was observed in the dermis.
The patient was diagnosed with Papilloma-
tosis papulosa confluens reticulata et pigmenta-
ta (Morbus Gougerot-Carteaud) on the ground of 
the typical clinical presentation and the histological 
examination. 
Treatment was initiated with 0.05% retinoic 
acid cream and 5% salycilic ointment. Full resolution 
of the lesions was observed after 1.5 months.
DISCUSSION
Papillomatosis papulosa confluens reticula-
ta et pigmentata was described first by Н. Gougerot 
and А. Carteaud in 1927. Initially they named it pap-
illomatose pigmentée innominée, and later on re-
named it to papillomatose pigmentée confluente et 
réticulée (10, 21). The etiology of the disease remains 
unknown. A reaction to Pityrosporum ovale was long 
thought to be the main triggering factor, but in 75% 
of patients the KOH staining for fungus is negative 
and the antifungal treatment is not effective (5). Oth-
er suspected etiological factors include endocrine 
disturbances (17), impaired keratinization, bacteri-
al infection with a newly found Actinomyces strain – 
Dietzia X (20), as well as an association with the cuta-
neous form of amyloidosis (11). Exposure to UV light 
could trigger or exacerbate the disease (28). Famil-
Fig. 1. Papillomatous, hyperpigmented, velvety plaques 
involving the abdomen
Fig. 2. Papillomatous, hyperpigmented, velvety plaques 
involving the back and sparing the area under the 
swimming suit straps
Fig. 3. Histological examination. H&E x100. Epidermal 
atrophy with hyperkeratosis, papillomatosis, vacuolar de-
generation and sparse infiltrate in the upper dermis
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ial forms are only rarely described (14,15), but they 
might be due to defects in keratinization. 
G. Miescher was the first to propose the idea 
of impaired keratinization as the pathophysiolog-
ic mechanism of PPCRP (19). This idea was further 
supported by electron microscopy and immunochis-
tochemical analysis. Electron microscopy shows an 
increased number of lamellar granules in stratum 
granulosum, transit cells between stratum granulo-
sum and stratum corneum and increase in the num-
ber of melanososmes in stratum corneum (16, 18). 
Immunohistochemical studies show increased ex-
pression of markers for keratinocyte differentiation 
and proliferation – involucrin, keratin 16 and Ki-67 
protein (15). Additional evidence to this hypothesis 
is the remarkable therapeutic effect of retinoids and 
vitamin D analogues whose main mechanism of ac-
tion is regulation of cellular differentiation and inhi-
bition of keratinocyte proliferation.
Ultraviolet light causes multiple variable chang-
es in skin structures and cellular elements. In the epi-
dermis the damage is presented by epidermal hyper-
plasia of stratum corneum with increased prolifera-
tion of keratinocytes, increased melanogenesis, de-
fective barrier function and keratinocyte DNA al-
terations (4). Immunohistochemically these changes 
translate into amplified expression of К6, К16, К17 
and Кi-67 (27). Besides the cellular morphological 
changes, UV light causes local and generalized im-
munosuppression. This immunosupression prevents 
an immunological reaction to the newly formed an-
tigents resulting from the keratynocyte DNA injury. 
It is now known that the genetically determined re-
sistance to UV-light-induced immunosupression is 
the pathogenetic reason for the development of poly-
morphic light eruption (29). 
Ultraviolet light could trigger the syndrome of 
Gougerot – Carteaud through several pathogenet-
ic mechanisms. UV-induced changes and PPCRP 
have similar immunohistochemical and histologi-
cal characteristics, both being characterized by en-
hanced proliferation and impaired keratinization. 
On the background of certain genetic predisposition 
UV changes may present clinically as PPCRP. On the 
other hand, similar to polymorphic light eruption, in 
our patient and in the other few UV-sensitive cases 
reported in the literature (20), the mechanism might 
be a genetically pre-determined resistance to the im-
munosuppressive action of UVB resulting in the 
characteristic epidermal reaction towards the new-
ly formed antigens. This hypothesis is supported by 
the successful treatment with minocycline and other 
antibiotics from the group of tetracyclines, that are 
known to have an immunomodulatory effect besides 
their antibacterial activity. (24) 
PPCRP is a benign dermatosis but its clinical 
presentation is cosmetically unacceptable and em-
barrasses the patients. Understanding the etiology 
and pathogenesis would help to specify the most op-
timal treatment.
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